While genetic ablation of Sarm1 was not neuroprotective in the SOD1G93A ALS mouse model [62], which typically lacks prominent TDP-43 pathology, this intervention did reduce neuron and axon loss in a transgenic TDP-43Q331K mouse model of ALS/FTD [85]. Here, SARM1 is linked to frontotemporal dementia.